HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,262,319 | +3.0% | 137,739 | -2.7% | 1.25% | +14.1% |
| Q2 2023 | $5,106,827 | +15.9% | 141,581 | +22.6% | 1.10% | +12.5% |
| Q1 2023 | $4,408,067 | -37.9% | 115,470 | -7.3% | 0.97% | -38.9% |
| Q4 2022 | $7,098,112 | +19.1% | 124,572 | -17.4% | 1.59% | +15.7% |
| Q3 2022 | $5,961,000 | -21.2% | 150,755 | -12.3% | 1.38% | -13.5% |
| Q2 2022 | $7,568,000 | -35.5% | 171,969 | -41.6% | 1.59% | -9.4% |
| Q1 2022 | $11,737,000 | -1.3% | 294,413 | -0.4% | 1.76% | +13.4% |
| Q4 2021 | $11,890,000 | – | 295,656 | – | 1.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |